Insights

Strategic Industry Partnerships Abolis Biotechnologies has recently formed significant collaborations with industry leaders such as L’Oréal and EuroAPI, indicating strong credibility and opportunity for expanding into beauty, healthcare, and chemical manufacturing sectors seeking sustainable solutions.

Funding Momentum The company secured substantial financing rounds, including a €35 million funding and a €140 million alliance, demonstrating financial vitality and potential for scaling operations or developing new product lines tailored to large industrial clients.

Focus on Sustainability Abolis emphasizes renewable raw materials, supply chain security, and greenhouse gas reduction, aligning with the growing market demand for eco-friendly and sustainable industrial solutions across multiple sectors including cosmetics and chemicals.

Innovative Collaborations Partnerships with HealthTech Bio Actives and Bon Vivant showcase opportunities to target health and wellness markets, especially in developing sustainable bioactive compounds such as polyphenols for nutraceutical or cosmetic applications.

Emerging Market Position With recent investments, strategic alliances, and an expanding client base, Abolis is well-positioned as a disruptive biotech innovator, making it an attractive prospect for businesses seeking to incorporate cutting-edge, sustainable biotechnologies into their manufacturing processes.

Abolis Biotechnologies Tech Stack

Abolis Biotechnologies uses 8 technology products and services including Google Cloud CDN, cdnjs, Brevo, and more. Explore Abolis Biotechnologies's tech stack below.

  • Google Cloud CDN
    Content Delivery Network
  • cdnjs
    Content Delivery Network
  • Brevo
    Live Chat
  • Envoy
    Load Balancers
  • Java
    Programming Languages
  • X-Content-Type-Options
    Web & Portal Technology
  • Piwik PRO Core
    Web Analytics
  • Apache
    Web Servers

Abolis Biotechnologies's Email Address Formats

Abolis Biotechnologies uses at least 1 format(s):
Abolis Biotechnologies Email FormatsExamplePercentage
First.Last@abolis.frJohn.Doe@abolis.fr
100%

Frequently Asked Questions

Where is Abolis Biotechnologies's headquarters located?

Minus sign iconPlus sign icon
Abolis Biotechnologies's main headquarters is located at 5 Rue Henri Desbruères Évry, Île-de-france France. The company has employees across 4 continents, including EuropeAsiaNorth America.

What is Abolis Biotechnologies's official website and social media links?

Minus sign iconPlus sign icon
Abolis Biotechnologies's official website is abolis.fr and has social profiles on LinkedInCrunchbase.

What is Abolis Biotechnologies's SIC code NAICS code?

Minus sign iconPlus sign icon
Abolis Biotechnologies's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Abolis Biotechnologies have currently?

Minus sign iconPlus sign icon
As of June 2026, Abolis Biotechnologies has approximately 67 employees across 4 continents, including EuropeAsiaNorth America. Key team members include Chief Scientific Officer: G. B.Vp Operations | Head Of Operations, Transformation & Change Management: F. A.Vp Business & Strategy: G. S.. Explore Abolis Biotechnologies's employee directory with LeadIQ.

What industry does Abolis Biotechnologies belong to?

Minus sign iconPlus sign icon
Abolis Biotechnologies operates in the Biotechnology Research industry.

What technology does Abolis Biotechnologies use?

Minus sign iconPlus sign icon
Abolis Biotechnologies's tech stack includes Google Cloud CDNcdnjsBrevoEnvoyJavaX-Content-Type-OptionsPiwik PRO CoreApache.

What is Abolis Biotechnologies's email format?

Minus sign iconPlus sign icon
Abolis Biotechnologies's email format typically follows the pattern of First.Last@abolis.fr. Find more Abolis Biotechnologies email formats with LeadIQ.

When was Abolis Biotechnologies founded?

Minus sign iconPlus sign icon
Abolis Biotechnologies was founded in 2014.

Abolis Biotechnologies

Biotechnology ResearchÎle-de-france, France51-200 Employees

Abolis is a French company delivering high-impact innovations in biotechnologies. We provide tailor-made industrial solutions based on micro-organisms.
Founded in 2014, Abolis is made up of a team of 66+ people. Determined to become a key player in the transformation of manufacturing, we reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals.
We rely on biotechnologies and the untapped potential of micro-organisms to develop new solutions economically viable.  
We take up the industry's current challenges by: 
·      Using renewable raw materials 
·      Relocate essential production and secure supply chains
·      Reducing greenhouse gas emissions 

Because each customer has its own unique story and challenges, we cultivate a multidisciplinary, tailor-made approach. Science, economics, intellectual property, industrial realities: each of our answers is based on the best possible practices. 
We are…
independent in thought and action
rigorous in our approach and the way we work
creative because we never stop innovating, while remaining pragmatic
ambitious because we are passionate and determined to make a difference

Section iconCompany Overview

Headquarters
5 Rue Henri Desbruères Évry, Île-de-france France
Website
abolis.fr
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
51-200

Section iconFunding & Financials

  • $1M

    Abolis Biotechnologies's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Abolis Biotechnologies's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.